Scientific Programme

Scientific Programme

Auditorium 2 - Fundação Calouste Gulbenkian

Thursday, 10 May 2018

 

9.00  - Opening Session – Jorge Soares, Leonor David and Luís Costa

 

Plenary Lectures

Chairs: João Barata, Leonor David

09.30 – 10.15 – EACR Lecture – Anton Berns (President of EACR; Netherlands Cancer Institute)

Mouse models of lung cancer. What do they teach us?

10.15 – 11.00 - ASEICA Lecture – Xosé Bustelo (Vice-President of ASEICA; Universidad de Salamanca)

Bivalents roles of Vav oncoproteins in cancer: Genetic evidence and potential translation to human settings

 

11.00 – 11.30 – Coffee break

 

11.30 – 13.00 - Symposium I – Invasion and Metastasis

Chairs: Joana Paredes and Bruno Costa Silva

11.30 – 11.45 – Selected oral presentation - Paulo de Sepúlveda (CRCM, INSERM)

Unexpected tumor suppression function for FES tyrosine kinase in cancer​

11.45 – 12.00 – Selected oral presentation - Carlos Custódia (IMM)

Patient-derived xenograft models of brain metastases for translational medicine 

12.00 - 12.30 - Invited speaker: Susana Godinho (Barts Cancer Institute)

Oxidative stress in cells with extra centrosomes drives non-cell autonomous invasion

12.30 – 13.00 - Invited speaker: Sandra Swain (Georgetown University Medical Center)

The path to success in HER2-positive breast cancer

 

13.00 – 14.00 – Lunch

 

14.00 – 16.00 – Poster Session - Rooms 1, 2 and Hall

 

16.00 – 17.30 - Symposium II – Therapy Resistance

Chairs: João Nuno Moreira and Isabel Fernandes

16.00 -16.30 - Invited speaker: Peter Nelson (Fred Hutchinson Cancer Research Center)

Therapy Resistance: The Emergence of New Cancer Species Evolving Through Treatment Pressures

16.30 – 17.00 Invited speaker: Daniel Peeper (Netherlands Cancer Institute)

Towards rational combinatorial cancer treatment — a functional genomics approach

17.00 – 17.15- Selected oral presentation - Vânia Palma Roberto (UAlg)

TERT methylation: a potential diagnostic and prognostic tool for the management of colorectal cancer​

17.15 – 17.30 – Selected oral presentation - Raquel Cruz-Duarte (IMM)

PLCγ1 Mediates Resistance to Anti-EGFR Therapy in Metastatic Colorectal Cancer

 

17.30 – 18.00 – Coffee break

 

18.00 – 19.00 - ASPIC General Assembly

 

20.00 - Congress Dinner

 

 

Friday, 11 May 2018

09.00 – 10.15 – Parallel workshops

WORKSHOP 1 - The importance of biomarker validation to increase success in cancer drug development and approval. (Organization: Júlio Oliveira, Lúcio Lara Santos, André Albergaria) - Room 3

WORKSHOP 2 - Consortium Kick-off Meeting: Building and promoting Excellence in Cholangiocarcinoma Sciences in Portugal. (Organization: Júlio Oliveira, Lúcio Lara Santos, André Albergaria) - Auditorium 3

WORKSHOP 3 - Presentation of the European Reference Network GENTURIS - Genetic tumour risk syndromes: opportunities to improve health care for patients with hereditary cancer syndromes in Europe. (Organization: Carla Oliveira and Tamara Hussong Milagre (patient association EVITA) - Auditorium 2

Speaker: Nicoline Hoogerbrugge (GENTURIS President)

 

ASPIC Plenary Lecture

Chairs: Luís Costa and Fátima Vaz

10.15 - 11.00 - Carlos Caldas (University of Cambridge)

A systems level panoramic view of breast cancer

 

11.00 – 11.30 – Coffee break

 

11.30 – 13.00 - Symposium III - New technologies / New achievements - Part 1

Chairs: Raquel Seruca and Lúcio Lara Santos

11.30 – 11.45 -  Selected oral presentation - Celine Gonçalves (ICVS - UMinho)

Functional and prognostic relevance of WNT6 in human glioblastoma

11.45 – 12.00 – Selected oral presentation - Maria José Oliveira (i3S/INEB)

Reprogramming antigen-presenting cells: a chitosan/γ-PGA nanoparticles for anticancer therapy

12.00 – 12.30 - Invited speaker: Luís Almeida (Blueclinical, Universidade do Porto)

Oncological R&D Pipeline – booming of mechanisms and targets

12.30 – 13.00 – Invited speaker: J. Iñaki Martin-Subero (IDIBAPS)

Decoding the epigenome of normal and neoplastic B cells: biological and clinical insights

 

13.00 – 14.00 – Lunch

 

14.00 – 15.30 - Symposium IV – Metabolism and Cancer

Chairs: Ana Preto and Manuel Sobrinho Simões

14.00 - 14.30 - Invited speaker: Michael P. Lisanti (University of Salford)

Cancer Stem Cells (CSCs): New Approaches to their Identification and Eradication

14.30 - 15.00 – Invited speaker: Carla Martins (University of Cambridge)

Targeting the metabolic dependencies of mutant Kras lung tumours

15.00  – 15.15 - Selected oral presentation - Soraia Melo (i3S/Ipatimup)

A novel regulation mechanism underlying loss of E-cadherin expression in Hereditary Diffuse Gastric Cancer families

15.15 – 15.30 – Selected oral presentation - Bruno A. Cardoso (IMM)

CASZ1 is overexpressed in T-cell acute lymphoblastic leukemia and promotes cell transformation and tumor growth via PI3K-mTOR

 

15.30 – 16.00 – Coffee break

 

16.00 – 17.30 – Symposium V – Host and Cancer (Immunotherapy)

Chairs: Sofia Braga and José Carlos Machado

16.00 – 16.30 – Invited Speaker: Christian Blank (Netherlands Cancer Institute)

Neo-adjuvant checkpoint inhibition – the pathway towards personalized immunotherapy

16.30 – 17.00 – Invited speaker: Cora Sternberg (San Camillo Forlanini Hospital)

Immunotherapy in the treatment of Urothelial Cancer (UC)

17.00 - 17.30 - Symposium III - New technologies / New achievements - Part 2

17.00 - 17.30 - Invited speaker: Leon Alkalai (NASA) - (Webex conference)

The Future of Robotic Space Exploration: from our Solar System to Interstellar Exploration. How Medicine can benefit from that knowledge?

 

17.30 – 18.00 - EACR awards and closing – Carlos Caldas, José Luís Passos Coelho, Jorge Soares and Luís Costa